Where:
MassBio
300
Cambridge, Massachusetts 02139
Admission:
FREE
Categories:
Business, Innovation, Lectures & Conferences, Tech
Event website:
http://events.r20.constantcontact.com/register/event?llr=l7sugnyab&oeidk=a07ef3wgg821c4496e7
Join academic, clinical, technology development and research stakeholders for a dialogue about emerging opportunities to treat hearing loss with therapeutics as well as new approaches for discovery, testing and treatment with the potential to rapidly accelerate therapeutic development.
Register by Feb. 27, 2018
Panelists and Themes
- Clinical and surgical perspective - Dr. Daniel J. Lee, M.D., ENT Surgeon, Massachusetts Eye and Ear Infirmary; Associate Professor, Harvard Medical School
- Patient perspective - Annahita Forghan, cochlear implant patient and PharmD student candidate
- Research perspective - Dr. David P. Corey, Ph.D., Bertarelli Professor of Translational Medical Science, Harvard Medical School -
- Preclinical model and efficacy assessment - Celia Belline, CEO, CILcare
- Safety assessment and combination product perspective - Peter M. Markham, CEO, CBSET
- Intracochlear Drug Delivery device (ICDD) - Dr. Jeffrey T. Borenstein, Ph.D., Draper Biomedical and Tissue Engineering
For more program information, see https://www.massbio.org/events/advancing-solutions-in-hearing-loss-program-2603.
Thursday, Jan 23, 2025 7:30p
The Neal Rantoul Vault Theatre
Saturday, Jan 18, 2025 4:30p
Honeybound Meadery
Tuesday, Jan 21, 2025 6:00p
Boston Area Spanish Exchange (BASE)
Saturday, Jan 25, 2025 9:30a
Shambhala Boston